{"id":"https://openalex.org/W184045013","doi":null,"title":"Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.","display_name":"Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.","publication_year":2007,"publication_date":"2007-06-01","ids":{"openalex":"https://openalex.org/W184045013","mag":"184045013","pmid":"https://pubmed.ncbi.nlm.nih.gov/17899953"},"language":"en","primary_location":{"id":"pmid:17899953","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17899953","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nepal Medical College journal : NMCJ","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079545326","display_name":"Adnan Agha","orcid":"https://orcid.org/0000-0002-2704-8931","observed_orcids":["https://orcid.org/0000-0002-2704-8931"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adnan Agha","raw_affiliation_strings":["Medical Unit I, Jinnah Hospital, Lahore, Pakistan. adnanagha@hotmail.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Unit I, Jinnah Hospital, Lahore, Pakistan. adnanagha@hotmail.com","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038607815","display_name":"Kaukab Bashir","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kaukab Bashir","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5053708903","display_name":"Eram Anwar","orcid":"https://orcid.org/0009-0006-9335-9208","observed_orcids":["https://orcid.org/0009-0006-9335-9208"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eram Anwar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2386,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.62517222,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"9","issue":"2","first_page":"79","last_page":"83"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/losartan","display_name":"losartan","score":1.0},{"id":"https://openalex.org/keywords/microalbuminuria","display_name":"microalbuminuria","score":0.9369999766349792},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9909999966621399},{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":0.9729999899864197},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.8759999871253967},{"id":"https://openalex.org/keywords/normotensive-subjects","display_name":"normotensive subjects","score":0.9419999718666077},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.6179999709129333},{"id":"https://openalex.org/keywords/renal-protection","display_name":"renal protection","score":0.7519999742507935},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.49000000953674316}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9646947383880615},{"id":"https://openalex.org/C2781203188","wikidata":"https://www.wikidata.org/wiki/Q1676817","display_name":"Microalbuminuria","level":3,"score":0.9435707926750183},{"id":"https://openalex.org/C2780288358","wikidata":"https://www.wikidata.org/wiki/Q410074","display_name":"Losartan","level":4,"score":0.8179786205291748},{"id":"https://openalex.org/C2779922275","wikidata":"https://www.wikidata.org/wiki/Q1129105","display_name":"Diabetic nephropathy","level":3,"score":0.6089084148406982},{"id":"https://openalex.org/C2776174234","wikidata":"https://www.wikidata.org/wiki/Q974792","display_name":"Albuminuria","level":3,"score":0.6027210354804993},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5987688899040222},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.5637178421020508},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5173822641372681},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.44408467411994934},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.4282161295413971},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3507603406906128},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.22968435287475586}],"mesh":[{"descriptor_ui":"D000419","descriptor_name":"Albuminuria","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000419","descriptor_name":"Albuminuria","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019808","descriptor_name":"Losartan","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019808","descriptor_name":"Losartan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":1,"locations":[{"id":"pmid:17899953","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17899953","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nepal Medical College journal : NMCJ","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1604542334","https://openalex.org/W1830527160","https://openalex.org/W1968446955","https://openalex.org/W1977075739","https://openalex.org/W1977269859","https://openalex.org/W1999917583","https://openalex.org/W2002080901","https://openalex.org/W2003670762","https://openalex.org/W2004164169","https://openalex.org/W2020267609","https://openalex.org/W2024635091","https://openalex.org/W2044773944","https://openalex.org/W2046809996","https://openalex.org/W2047680488","https://openalex.org/W2056976690","https://openalex.org/W2057105818","https://openalex.org/W2064568136","https://openalex.org/W2064927835","https://openalex.org/W2088462304","https://openalex.org/W2097288698","https://openalex.org/W2098154750","https://openalex.org/W2101337813","https://openalex.org/W2104916280","https://openalex.org/W2114026537","https://openalex.org/W2118286022","https://openalex.org/W2133568993","https://openalex.org/W2185279615","https://openalex.org/W2296903449","https://openalex.org/W2332607769","https://openalex.org/W2408042400","https://openalex.org/W2442062721","https://openalex.org/W4242344507"],"related_works":["https://openalex.org/W1524165594","https://openalex.org/W7096277038","https://openalex.org/W2066956266","https://openalex.org/W2104916280","https://openalex.org/W2381701256","https://openalex.org/W7159758054","https://openalex.org/W2292220891","https://openalex.org/W2114034422","https://openalex.org/W4238992471","https://openalex.org/W2385014814"],"abstract_inverted_index":{"Type-2":[0],"diabetes":[1],"mellitus":[2],"(T2DM)":[3],"is":[4,14,23,31,85],"a":[5,15,154],"global":[6],"disease":[7,64],"and":[8,30,50,58,77,131,138,170,201,222,230,258],"its":[9,280],"resultant":[10],"complication,":[11],"diabetic":[12,28,286],"nephropathy,":[13],"leading":[16],"cause":[17],"of":[18,27,62,96,125,174,184,187,198,204,207,237,252,271],"chronic":[19],"renal":[20,63],"failure.":[21],"Microalbuminuria":[22],"an":[24,33],"early":[25,268],"indicator":[26],"nephropathy":[29,79,269],"also":[32],"independent":[34,270],"risk":[35],"factor":[36],"for":[37,153,285],"cardiovascular":[38],"morbidity.":[39],"Data":[40],"have":[41],"shown":[42],"that":[43],"anti-hypertensives":[44],"like":[45],"Angiotensin":[46,51],"receptor":[47],"blockers":[48],"(ARB),":[49],"converting":[52],"enzyme":[53],"inhibitors":[54],"(ACEI)":[55],"reduce":[56],"microalbuminuria":[57,76,132,142,178],"retards":[59],"the":[60,71,93,144,163,182,188,202,245],"progression":[61],"effectively":[65],"in":[66,80,99,211,263],"hypertensive":[67],"T2DM":[68,84,101,130,266],"patients.":[69,102],"But":[70],"effects":[72,95,173,236,262],"ofARBs":[73],"on":[74,149,243],"preventing":[75],"ensuing":[78],"normotensive":[81,100,127],"patients":[82,128,146,264],"with":[83,129,228,231,265,267],"yet":[86],"to":[87,161,278],"be":[88],"fully":[89],"established.":[90],"To":[91],"assess":[92],"anti-microalbuminuric":[94],"losartan":[97,150,175,238],"therapy":[98,284],"Interventional":[103],"Phase":[104],"Two":[105],"Clinical":[106],"Trial":[107],"was":[108,111,179,213,255],"done.":[109],"Study":[110],"done":[112,160],"at":[113,181],"Diabetic":[114],"Clinic,":[115],"Jinnah":[116],"Hospital":[117],"Lahore,":[118],"Pakistan":[119],"over":[120],"8":[121],"months.":[122],"A":[123],"total":[124],"171":[126,189],"were":[133,147,159,239],"evaluated.":[134],"After":[135],"informed":[136],"consent":[137],"baseline":[139,200,221],"24-hour":[140],"urinary":[141,246],"quantification":[143],"selected":[145],"started":[148],"50":[151],"mg/day":[152],"six-month":[155],"period.":[156],"Monthly":[157],"follow-ups":[158],"monitor":[162],"blood":[164],"pressure,":[165],"glycemic":[166],"control,":[167],"urea/creatinine/potassium":[168],"levels":[169],"any":[171],"untoward":[172],"therapy.":[176],"Quantitative":[177],"repeated":[180],"end":[183],"study.":[185],"Out":[186],"patients,":[190],"149":[191],"(87.1%)":[192],"had":[193],"significant":[194,260],"albuminuria":[195],"reduction":[196],">30.0%":[197],"their":[199],"variable":[203],"final":[205],"outcome":[206],"intervention":[208],"(urinary":[209],"albumin":[210,247],"mg/dl)":[212],"significantly":[214],"reduced":[215],"(Mean":[216],"101.9":[217],"+/-":[218,224],"SD":[219],"21.7":[220],"47.5":[223],"12.9":[225],"post":[226],"therapy)":[227],"p<0.001":[229],"minimal":[232],"side-effects.":[233],"These":[234],"anti-albuminuric":[235],"reversible":[240],"as":[241,282],"seen":[242],"rechecking":[244],"two":[248],"months":[249],"after":[250],"discontinuation":[251],"treatment.":[253],"Losartan":[254],"well":[256],"tolerated":[257],"demonstrated":[259],"anti-proteinuric":[261],"hypertension,":[272],"warranting":[273],"further":[274],"long-term":[275],"large-scale":[276],"studies":[277],"prove":[279],"usefulness":[281],"preventive":[283],"nephropathy.":[287]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}